Trial Profile
Effect of Gut Decontamination Using Rifaximin in the Patients With Severe Alcoholic Hepatitis
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 10 Dec 2020
Price :
$35
*
At a glance
- Drugs Rifaximin (Primary) ; Corticosteroid; Pentoxifylline
- Indications Alcoholic hepatitis
- Focus Therapeutic Use
- 02 Dec 2020 Status changed from not yet recruiting to recruiting as per results published in the Alimentary Pharmacology and Therapeutics.
- 02 Dec 2020 Results (n=48) assessing microbiome as a potential diagnostic and predictive biomarker in severe alcoholic hepatitis, published in the Alimentary Pharmacology and Therapeutics
- 08 Jul 2015 New trial record